SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (333)12/30/1998 11:41:00 PM
From: Larry Liebman   of 1073
 
Just received a quarterly report from CBMI. For the first time in months I was favorably impressed. Noted that CBMI moved quietly higher today. If I read this correctly, Stryker pays them 20 million for factory/manufacturing rights, and "substantially" increases royalties for certain OP-1 indications. When this is completed, CBMI has 60 million in cash. With CBMI at $3+, this might be another in the universe of "executed biotechs" that could prove valuable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News